JP2002518010A5 - - Google Patents

Download PDF

Info

Publication number
JP2002518010A5
JP2002518010A5 JP2000554850A JP2000554850A JP2002518010A5 JP 2002518010 A5 JP2002518010 A5 JP 2002518010A5 JP 2000554850 A JP2000554850 A JP 2000554850A JP 2000554850 A JP2000554850 A JP 2000554850A JP 2002518010 A5 JP2002518010 A5 JP 2002518010A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide
polynucleotide
nucleic acid
atcc deposit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000554850A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002518010A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/013418 external-priority patent/WO1999066041A1/en
Publication of JP2002518010A publication Critical patent/JP2002518010A/ja
Publication of JP2002518010A5 publication Critical patent/JP2002518010A5/ja
Pending legal-status Critical Current

Links

JP2000554850A 1998-06-16 1999-06-15 ９４個のヒト分泌タンパク質 Pending JP2002518010A (ja)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US8950798P 1998-06-16 1998-06-16
US8951098P 1998-06-16 1998-06-16
US8950898P 1998-06-16 1998-06-16
US8950998P 1998-06-16 1998-06-16
US60/089,509 1998-06-16
US60/089,510 1998-06-16
US60/089,507 1998-06-16
US60/089,508 1998-06-16
US9011298P 1998-06-22 1998-06-22
US9011398P 1998-06-22 1998-06-22
US60/090,112 1998-06-22
US60/090,113 1998-06-22
PCT/US1999/013418 WO1999066041A1 (en) 1998-06-16 1999-06-15 94 human secreted proteins

Publications (2)

Publication Number Publication Date
JP2002518010A JP2002518010A (ja) 2002-06-25
JP2002518010A5 true JP2002518010A5 (enExample) 2006-08-03

Family

ID=27557361

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000554850A Pending JP2002518010A (ja) 1998-06-16 1999-06-15 ９４個のヒト分泌タンパク質

Country Status (6)

Country Link
US (4) US6475753B1 (enExample)
EP (1) EP1088071A4 (enExample)
JP (1) JP2002518010A (enExample)
AU (1) AU4682999A (enExample)
CA (1) CA2331154A1 (enExample)
WO (1) WO1999066041A1 (enExample)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1445322B2 (en) 1995-06-15 2012-06-06 Crucell Holland B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
WO1999066041A1 (en) 1998-06-16 1999-12-23 Human Genome Sciences, Inc. 94 human secreted proteins
WO2000070050A1 (en) * 1999-05-14 2000-11-23 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US20030166107A1 (en) * 1997-09-18 2003-09-04 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6391311B1 (en) * 1998-03-17 2002-05-21 Genentech, Inc. Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1
US7723488B2 (en) * 1998-03-27 2010-05-25 Genentech, Inc. Monoclonal antibodies to secreted and transmembrane polypeptides
US7371836B2 (en) * 1998-03-27 2008-05-13 Genentech, Inc. PRO526 nucleic acids
US20070020724A1 (en) 1998-06-16 2007-01-25 Ruben Steven M 94 human secreted proteins
US7538086B2 (en) * 1998-09-01 2009-05-26 Genentech, Inc. PRO1303 polypeptides
US7399834B2 (en) * 1998-10-07 2008-07-15 Genentech, Inc. Anti-PRO1558 antibodies
US7026449B2 (en) * 1999-01-05 2006-04-11 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
DK1607402T3 (da) * 1999-03-08 2007-04-16 Genentech Inc Sammensætninger og fremgangsmåder til tumorbehandling
US20050164386A1 (en) * 1999-04-15 2005-07-28 Uytdehaag Alphonsus G. Overexpression of enzymes involved in post-translational protein modifications in human cells
US7297680B2 (en) * 1999-04-15 2007-11-20 Crucell Holland B.V. Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content
US20060099685A1 (en) * 1999-04-15 2006-05-11 Yallop Christopher A Recombinant expression of factor VIII in human cells
US7604960B2 (en) * 1999-04-15 2009-10-20 Crucell Holland B.V. Transient protein expression methods
US8236561B2 (en) * 1999-04-15 2012-08-07 Crucell Holland B.V. Efficient production of IgA in recombinant mammalian cells
US6855544B1 (en) * 1999-04-15 2005-02-15 Crucell Holland B.V. Recombinant protein production in a human cell
US20050079577A1 (en) * 1999-05-14 2005-04-14 Ashkenazi Avi J. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6500940B1 (en) * 1999-06-09 2002-12-31 The Salk Institute For Biological Studies Lifeguard (LFG) polynucleotides and polypeptides and methods of use thereof
US6114123A (en) * 1999-06-14 2000-09-05 Incyte Pharmaceuticals, Inc. Lipocalin family protein
US6369210B1 (en) * 1999-06-30 2002-04-09 Millennium Pharmaceuticals, Inc. 22012, human carboxypeptidase
AU5979300A (en) * 1999-07-02 2001-01-22 Bayer Aktiengesellschaft Angiopoietin-6 and uses thereof
EP1233777A4 (en) * 1999-11-24 2003-07-16 Human Genome Sciences Inc MAJOR INTRINSIC PROTEIN (MIP) -LIKE POLYNUCLEOTIDES, POLYPEPTIDES AND ANTIBODIES
US7521220B2 (en) * 1999-11-26 2009-04-21 Crucell Holland B.V. Production of vaccines
US7192759B1 (en) * 1999-11-26 2007-03-20 Crucell Holland B.V. Production of vaccines
US7527961B2 (en) * 1999-11-26 2009-05-05 Crucell Holland B.V. Production of vaccines
US7119165B2 (en) 2000-01-12 2006-10-10 Yale University Nogo receptor-mediated blockade of axonal growth
PL356887A1 (en) * 2000-01-12 2004-07-12 Yale University Nogo receptor-mediated blockade of axonal growth
WO2001060854A1 (en) * 2000-02-14 2001-08-23 The Regents Of The University Of California Novel members of the h+/oligopeptide transporter gene family
US20030017585A1 (en) * 2000-02-25 2003-01-23 Andro Hsu Novel sodium/solute symporter-like protein and nucleic acids encoding same
US7070947B2 (en) 2000-02-29 2006-07-04 Millennium Pharmaceuticals, Inc. Human protein kinase, phosphatase, and protease family members and uses thereof
CA2401645A1 (en) * 2000-02-29 2001-09-07 Lexicon Genetics Incorporated Novel human transporter proteins and polynucleotides encoding the same
AU2001245693A1 (en) * 2000-03-16 2001-10-03 Northwest Biotherapeutics, Inc. Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses
AU2001249929A1 (en) * 2000-04-07 2001-10-23 Dana-Farber Cancer Institute Inc. Fdrg proteins and nucleic acid molecules and uses therefor
CA2401290A1 (en) * 2000-04-12 2001-10-18 Takeda Chemical Industries, Ltd. Novel g protein-coupled receptor protein and dna thereof
AU2001253488A1 (en) * 2000-04-14 2001-10-30 Millennium Pharmaceuticals, Inc. 33556, a novel human transporter and uses thereof
AU2001257378A1 (en) * 2000-04-29 2001-11-12 Millennium Pharmaceuticals, Inc. 23949 and 32391, human ion channels and uses thereof
US20050170413A1 (en) * 2000-07-03 2005-08-04 Applera Corporation Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof
GB2371546A (en) * 2000-09-12 2002-07-31 Smithkline Beecham Corp G protein coupled receptor AXOR 109
CA2420192A1 (en) * 2000-09-20 2002-03-28 Human Genome Sciences, Inc. 21 human secreted proteins
DE60141409D1 (de) 2000-10-06 2010-04-08 Biogen Idec Inc Homologe des nogo rezeptors
ATE466939T1 (de) * 2000-11-17 2010-05-15 Banyu Pharma Co Ltd Verfahren zur suche nach komponenten, in dem das guanosintriphosphat- (gtp-) bindungsprotein gekoppeltes rezeptorprotein bg37 verwendet wird
UA79927C2 (en) * 2000-12-05 2007-08-10 Serono Genetics Inst Sa Polynucleotide, coding a polypeptide of potential-depending portal ionic human channel (canion), polypeptyde, antibody, method for identification of candidate modulator of canion-polypeptyde, method for treatment of bipolar disorder or schizophrenia and use of an antibody for production of drugs for treatment of schizophrenia or bipolar disorder
EP1378749A4 (en) 2001-04-12 2005-05-11 Takeda Pharmaceutical SCREENING METHOD
JP2004535787A (ja) * 2001-04-13 2004-12-02 インサイト・ゲノミックス・インコーポレイテッド 酵素
DE60228559D1 (de) * 2001-04-25 2008-10-09 Astellas Pharma Inc Guanosintriphosphat-bindungsprotein-gekoppelter rezeptor place 6002312 und sein gen sowie dessen produktion und verwendung
EP1385962A2 (en) * 2001-05-02 2004-02-04 Bayer HealthCare AG Human prolyl 4-hydroxylases
EP1390391A4 (en) * 2001-05-25 2005-03-30 Incyte Genomics Inc CONVEYORS AND IONIC CHANNELS
CA2399569A1 (en) * 2001-09-25 2003-03-25 Yusuke Nakamura Diagnostic markers and drug targets for treatment of cancer
US20050123925A1 (en) 2002-11-15 2005-06-09 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
KR100979025B1 (ko) * 2001-12-07 2010-08-30 크루셀 홀란드 비.브이. 바이러스, 바이러스 단리물 및 백신의 생산
HUP0501017A3 (en) * 2001-12-14 2010-06-28 Targacept Methods and compositions for treatment of central nervous system disorders
MXPA05001615A (es) * 2002-08-10 2005-08-19 Biogen Idec Inc Antagonistas del nogo receptor.
US20040214237A1 (en) * 2002-10-03 2004-10-28 Synaptic Pharmaceutical Corporation DNA encoding SNORF138 and uses thereof
AU2004231742A1 (en) * 2003-04-16 2004-11-04 Biogen Idec Ma Inc. Nogo-receptor antagonists for the treatment of conditions involving amyloid plaques
ATE414144T1 (de) 2003-05-09 2008-11-15 Crucell Holland Bv Kulturen von e1-immortalisierten zellen und verfahren zu deren kultivierung zur erhöhung der produktausbeuten davon
DK1626992T3 (da) * 2003-05-23 2010-09-20 Crucell Holland Bv Produktion af rekombinant IgM i PER.C6-celler
CA2535007A1 (en) * 2003-08-07 2005-02-24 Biogen Idec Ma Inc. Nogo receptor antagonists
EP1678325A2 (en) * 2003-09-30 2006-07-12 Chiron Corporation Novel splice variants of human dkkl1
DE10350409A1 (de) * 2003-10-28 2005-05-25 Bayer Healthcare Ag Behandlung genetisch bedingter Krankheiten
US20070160680A1 (en) * 2004-02-12 2007-07-12 Rush University Medical Center Fluid composition used to stimulate human synovial fluid
US7189691B2 (en) * 2004-04-01 2007-03-13 The Administrators Of The Tulane Educational Fund Methods and compositions for treating leukemia
US20050281740A1 (en) * 2004-06-16 2005-12-22 Glen Gong Imaging damaged lung tissue
US20050281739A1 (en) * 2004-06-16 2005-12-22 Glen Gong Imaging damaged lung tissue using compositions
US7678767B2 (en) 2004-06-16 2010-03-16 Pneumrx, Inc. Glue compositions for lung volume reduction
US7608579B2 (en) * 2004-06-16 2009-10-27 Pneumrx, Inc. Lung volume reduction using glue compositions
US7468350B2 (en) 2004-06-16 2008-12-23 Pneumrx, Inc. Glue composition for lung volume reduction
US7553810B2 (en) * 2004-06-16 2009-06-30 Pneumrx, Inc. Lung volume reduction using glue composition
US20050281798A1 (en) * 2004-06-16 2005-12-22 Glen Gong Targeting sites of damaged lung tissue using composition
CA2570261C (en) 2004-07-08 2014-06-10 Pneumrx, Inc. Pleural effusion treatment device, method and material
MX2007000783A (es) 2004-07-20 2007-04-09 Genentech Inc Inhibidores de proteina angiopoietina tipo 4, combinaciones y su uso.
US8604185B2 (en) 2004-07-20 2013-12-10 Genentech, Inc. Inhibitors of angiopoietin-like 4 protein, combinations, and their use
AU2005269716B2 (en) * 2004-07-20 2011-01-27 Genentech, Inc. Inhibitors of angiopoietin-like 4 protein, combinations, and their use
WO2006047049A2 (en) * 2004-10-01 2006-05-04 Yale University Nogo-a polypeptide fragments, variant nogo receptor-1 polypeptides, and uses thereof
WO2006089218A2 (en) * 2005-02-17 2006-08-24 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for modulating angiogenesis
US8252267B2 (en) 2005-03-30 2012-08-28 Sagres Discovery, Inc. DKKL-1 splice product modulators for cancer diagnosis and therapy
EP1904091A4 (en) 2005-07-07 2009-12-23 Univ Yale COMPOSITIONS AND METHODS FOR SUPPRESSING THE INHIBITION OF AXON GROWTH
WO2007025219A2 (en) * 2005-08-25 2007-03-01 Biogen Idec Ma Inc. Nogo receptor polypeptides and polypeptide fragments and uses thereof
WO2007089601A2 (en) 2006-01-27 2007-08-09 Biogen Idec Ma Inc. Nogo receptor antagonists
EP2023735A4 (en) * 2006-05-15 2011-05-25 Biogen Idec Inc USE OF ANTAGONISTS OF THE NOGO RECEPTOR 1 (NGR1) TO PROMOTE THE SURVIVAL OF OLIGODENDROCYTES
US8568286B2 (en) * 2006-06-14 2013-10-29 Cardiac Pacemakers, Inc. Methods to position therapeutic agents using a magnetic field
US20100297218A1 (en) * 2006-09-20 2010-11-25 Pneumrx, Inc. Tissue adhesive compositions and methods thereof
US20090053831A1 (en) * 2007-05-01 2009-02-26 Cell Signaling Technology, Inc. Tyrosine phosphorylation sites
US20080313166A1 (en) * 2007-06-15 2008-12-18 Microsoft Corporation Research progression summary
US9128981B1 (en) 2008-07-29 2015-09-08 James L. Geer Phone assisted ‘photographic memory’
US8775454B2 (en) * 2008-07-29 2014-07-08 James L. Geer Phone assisted ‘photographic memory’
ES2338515B1 (es) * 2008-11-06 2011-09-14 Consejo Superior De Investigaciones Cientifica (Csic) 80% Metodo de deteccion de la telangiectasia hemorragica hereditaria.
MY196837A (en) * 2015-12-11 2023-05-03 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against various cancers

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011912A (en) * 1986-12-19 1991-04-30 Immunex Corporation Hybridoma and monoclonal antibody for use in an immunoaffinity purification system
AU652537B2 (en) 1988-11-04 1994-09-01 Erziehungsdirektion Of The Canton Zurich Neurite growth regulatory factors
CA1341050C (en) 1988-11-04 2000-07-11 Martin E. Schwab Neurite growth regulatory factors
US5250414A (en) 1988-11-04 1993-10-05 Erziehungsdirektion Of The Canton Zurich Diagnostic methods using neurite growth regulatory factors
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
GB9409396D0 (en) * 1994-05-11 1994-06-29 Ciba Geigy Ag Cytokine regulated transcription factor
WO2000073452A2 (en) 1999-06-02 2000-12-07 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
EP1591529A3 (en) * 1995-07-19 2005-11-09 Genetics Institute, LLC Human CLTA-8 and uses of CTLA-8-related proteins
WO1999066041A1 (en) 1998-06-16 1999-12-23 Human Genome Sciences, Inc. 94 human secreted proteins
WO2000070050A1 (en) 1999-05-14 2000-11-23 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
DK1490386T3 (da) 1998-03-10 2008-12-15 Genentech Inc Nyt polypeptid og nukleinsyrer kodende for dette
ATE458050T1 (de) 1998-12-01 2010-03-15 Genentech Inc Promotion oder inhibition von angiogenese und kardiovaskularisation
JP3993746B2 (ja) 1998-12-22 2007-10-17 ジェネンテック・インコーポレーテッド 腫瘍性細胞成長阻害のための組成物及び方法
KR20010103046A (ko) 1999-03-08 2001-11-17 제넨테크, 인크. 면역 관련 질환 치료용 조성물 및 치료 방법
AU2883600A (en) 1999-03-08 2000-09-28 Genentech Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1686134A3 (en) 1999-12-01 2006-08-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
PL356887A1 (en) 2000-01-12 2004-07-12 Yale University Nogo receptor-mediated blockade of axonal growth

Similar Documents

Publication Publication Date Title
JP2002518010A5 (enExample)
JP2002521055A5 (enExample)
JP2002502589A5 (enExample)
JP2002516103A5 (enExample)
CA2364567A1 (en) Human breast and ovarian cancer associated gene sequences and polypeptides
Ohkuma et al. Structural motifs and potential a homologies in the large subunit of human general transcription factor TFIIE
JP2002506625A5 (enExample)
CA2302808A1 (en) 50 human secreted proteins
CA2323776A1 (en) Cytokine receptor common gamma chain like
JP2001511347A5 (enExample)
CA2247285A1 (en) Human tumor necrosis factor delta and epsilon
CA2343655A1 (en) Interleukin 17-like receptor protein
CA2309783A1 (en) Fibroblast growth factor-19
JP2002522041A5 (enExample)
CA2225189A1 (en) Canine factor viii gene, protein and methods of use
JP3681384B2 (ja) Ｇｄｐ交換因子活性を有するペプチド，それらのペプチドをコードする核酸配列，調製法，およびに，使用
KR950704484A (ko) 전사인자 DP-1(Transcription factor DP-1)
JP2002538789A5 (enExample)
WO2000023588B1 (en) G-protein coupled receptors
JP2005518212A5 (enExample)
CA2294472A1 (en) Torsin, torsin genes, and methods of use
WO2000000607B1 (en) A nucleic acid encoding a retinoblastoma binding protein (rbp-7) and polymorphic markers associated with said nucleic acid
JP2002512005A5 (enExample)
JP2002504333A5 (enExample)
JP3989536B2 (ja) ガラニンレセプター、核酸、形質転換細胞、およびそれらの使用